PTGS2 and gastric cancer: Studies found that both cell proliferation and PGE2 levels were significantly reduced following COX-2 inhibition; additionally, both COX-2 inhibitors and PGE2 receptors (EP2) antagonists could inhibit angiogenesis and tumor invasion in GC cells [43].